Victrex (LON:VCT) Stock Price Passes Above Two Hundred Day Moving Average – Here’s What Happened

Victrex plc (LON:VCT) shares crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 1,004.35 ($12.41) and traded as high as GBX 1,058 ($13.08). Victrex shares last traded at GBX 1,024 ($12.66), with a volume of 143,353 shares.

Wall Street Analyst Weigh In

Separately, Berenberg Bank cut their price target on shares of Victrex from GBX 1,290 ($15.95) to GBX 1,170 ($14.46) and set a “hold” rating on the stock in a report on Wednesday, December 4th.

Victrex Stock Performance

The stock has a 50 day simple moving average of GBX 980.96 and a 200 day simple moving average of GBX 1,004.35. The company has a quick ratio of 1.99, a current ratio of 5.30 and a debt-to-equity ratio of 16.99. The company has a market cap of £891.19 million, a price-to-earnings ratio of 2,925.71, a PEG ratio of 1.92 and a beta of 0.69.

Victrex Increases Dividend

The company also recently disclosed a dividend, which will be paid on Friday, February 21st. Stockholders of record on Thursday, January 23rd will be paid a dividend of GBX 46.14 ($0.57) per share. The ex-dividend date is Thursday, January 23rd. This represents a dividend yield of 5.26%. This is a positive change from Victrex’s previous dividend of $13.42. Victrex’s dividend payout ratio (DPR) is currently 17,142.86%.

Insider Transactions at Victrex

In related news, insider Brendan Connolly purchased 980 shares of the company’s stock in a transaction that occurred on Tuesday, December 3rd. The stock was acquired at an average price of GBX 1,019 ($12.60) per share, for a total transaction of £9,986.20 ($12,343.88). Also, insider Ian Melling acquired 2,000 shares of Victrex stock in a transaction on Friday, December 13th. The shares were bought at an average price of GBX 1,135 ($14.03) per share, for a total transaction of £22,700 ($28,059.33). Corporate insiders own 1.64% of the company’s stock.

About Victrex

Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.